244 related articles for article (PubMed ID: 25152585)
1. Novel therapeutic targets for pancreatic cancer.
Tang SC; Chen YC
World J Gastroenterol; 2014 Aug; 20(31):10825-44. PubMed ID: 25152585
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
Matsuoka T; Yashiro M
World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.
Onishi H; Katano M
World J Gastroenterol; 2014 Mar; 20(9):2335-42. PubMed ID: 24605030
[TBL] [Abstract][Full Text] [Related]
4. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
5. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
Lin YH; Wu MH; Yeh CT; Lin KH
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
[TBL] [Abstract][Full Text] [Related]
7. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.
Lonardo E; Hermann PC; Mueller MT; Huber S; Balic A; Miranda-Lorenzo I; Zagorac S; Alcala S; Rodriguez-Arabaolaza I; Ramirez JC; Torres-Ruíz R; Garcia E; Hidalgo M; Cebrián DÁ; Heuchel R; Löhr M; Berger F; Bartenstein P; Aicher A; Heeschen C
Cell Stem Cell; 2011 Nov; 9(5):433-46. PubMed ID: 22056140
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.
Tanase CP; Neagu AI; Necula LG; Mambet C; Enciu AM; Calenic B; Cruceru ML; Albulescu R
World J Gastroenterol; 2014 Aug; 20(31):10790-801. PubMed ID: 25152582
[TBL] [Abstract][Full Text] [Related]
9. TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment.
Abdel Mouti M; Pauklin S
Mol Ther; 2021 Mar; 29(3):920-936. PubMed ID: 33429081
[TBL] [Abstract][Full Text] [Related]
10. New targeted therapies in pancreatic cancer.
Seicean A; Petrusel L; Seicean R
World J Gastroenterol; 2015 May; 21(20):6127-45. PubMed ID: 26034349
[TBL] [Abstract][Full Text] [Related]
11. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.
Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł
Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978
[TBL] [Abstract][Full Text] [Related]
12. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer.
Garajová I; Balsano R; Tommasi C; Giovannetti E
Curr Pharm Des; 2018; 24(39):4601-4604. PubMed ID: 30659532
[TBL] [Abstract][Full Text] [Related]
13. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
[TBL] [Abstract][Full Text] [Related]
14. c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer.
Delitto D; Vertes-George E; Hughes SJ; Behrns KE; Trevino JG
World J Gastroenterol; 2014 Jul; 20(26):8458-70. PubMed ID: 25024602
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer stem cells: emerging target for designing novel therapy.
Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.
Neureiter D; Jäger T; Ocker M; Kiesslich T
World J Gastroenterol; 2014 Jun; 20(24):7830-48. PubMed ID: 24976721
[TBL] [Abstract][Full Text] [Related]
18. Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.
Tang YT; Xu XH; Yang XD; Hao J; Cao H; Zhu W; Zhang SY; Cao JP
World J Gastroenterol; 2014 Jul; 20(28):9405-17. PubMed ID: 25071335
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.
Barman S; Fatima I; Singh AB; Dhawan P
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946266
[TBL] [Abstract][Full Text] [Related]
20. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
